Archive for the ‘research’ Category

What Might Sudden Cardiac Death Due To Lyme Disease Look Like?

https://danielcameronmd.com/autopsy-study-reviews-cases-due-to-sudden-cardiac-death-from-lyme-disease/

WHAT MIGHT SUDDEN CARDIAC DEATH DUE TO LYME DISEASE LOOK LIKE?

What might sudden cardiac death due to Lyme disease look like?

“Although rare, sudden cardiac death caused by Lyme disease might be an under-recognized entity,” according to researchers who describe their findings from an autopsy study on 5 case patients who died from sudden cardiac death and were found post mortem to have Lyme carditis. The cases are discussed in an article entitled Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis, published in The American Journal of Pathology.

Fatal Lyme carditis is rarely identified. In reviewing five post mortem cases, Muehlenbach and colleagues found that Lyme disease was not suspected for one patient who complained of episodic shortness of breath, while the second patient tested negative for Lyme disease. Two other patients did not seek medical care. Details regarding the fifth patient were not released.

Ultimately, two case patients were diagnosed during unexplained-death investigations at the Centers for Disease Control and Prevention (CDC). Lyme disease was suspected in two of the other cases by cardiac pathology at a tissue bank transplant service. Muehlenbachs and colleagues reassure the readers that cardiac tissue was not transplanted. [1]

Autopsies reveal several findings

Spirochetes were present in the heart on all 5 cases. When using immunohistochemistry (IHC), spirochetes were found “within the myocardial interstitial infiltrates, in the subendocardium, and occasionally in pericardial tissue in association with lymphohistiocytic infiltrates.” Muehlenbachs adds, “Rare spirochetes were seen in the leptomeninges of two cases by immunohistochemistry.”

All 5 cases lived in Lyme-endemic areas. Patients resided in counties with a high or moderate incidence of Lyme disease including, New York, New Hampshire (with recent travel to Connecticut), Massachusetts and Indiana.

All 5 cases reportedly engaged in outdoor activities. “Two patients had known exposure to ticks, and one patient reported a recent bite.”

None of the 5 cases met the CDC surveillance case definition for Lyme carditis. This definition includes: recurrent, brief attacks (weeks or months) of objective joint swelling in one or several joints; lymphocytic meningitis; cranial neuritis; radiculoneuropathy; encephalomyelitis; acute onset of high-grade (2nd-degree or 3rd-degree) atrioventricular conduction defects, and myocarditis.

Only 1 of the 5 cases underwent serologic screening for Lyme disease and the results were negative.

All 5 cases were symptomatic prior to their death. “A prodrome was reported for each of the patients that included the following: non-specific viral-like illness, malaise, shortness of breath, and anxiety,” according to Muehlenbachs. “One of these patients also had joint and muscle pain, and the other two patients had joint pain for an unknown duration.”

No dermatologic lesion was documented or reported for any of the patients, although one patient was evaluated in an emergency department 1 month before death for an arm lesion diagnosed as a possible spider bite from which methicillin-resistant Staphylococcus aureus was isolated in culture.”

“Providers should consider Lyme disease in patients who have cardiac symptoms and exposure in an endemic area.” [1]

All 5 cases were seropositive post mortem according to the CDC’s two-tier criteria. “One sample met both IgM and IgG Western Blot (WB) criteria, with two of the three IgM bands and 6 of the 10 IgG bands reactive. The four remaining samples were positive by IgM WB criteria only, although three were nearly IgG positive with 4 of the 10 bands reactive,” states Muehlenbachs.

Underlying cardiac disease may have played a role in 3 of the 5 cases of sudden cardiac deaths associated with Lyme disease, Muehlenbachs points out, since there was significant underlying heart disease present in two patients, and an additional patient had moderate atherosclerosis, discovered at autopsy.

Physiological cardiac stress was considered a potential factor in 2 of the 5 cases. “In the other two patients, who were otherwise healthy, a degree of physiological cardiac stress likely was present: the woman had given birth 6 months previously and the man was a physically active outdoor enthusiast,” according to Muehlenbachs.

These pathologic findings provide insight into the possible cause behind sudden cardiac deaths associated with Lyme disease. “The findings support the proposed disease mechanism of spirochete cardiac tropism during early disease dissemination, the infiltration of cardiac tissue by inflammatory cells, and involvement of the conduction system, which likely mediates sudden cardiac death.” [1]

Is early diagnosis and prompt treatment possible?

“Early diagnosis and prompt treatment for Lyme carditis can be life-saving,” according to Muehlenbachs. “Health care professionals should evaluate all patients with suspected Lyme disease for cardiac signs and symptoms, and obtain an electrocardiogram promptly if carditis is suspected.” Furthermore, “diagnosis is based on clinical suspicion and serologic testing, with the caveat that serology testing may be falsely negative in a patient with recent illness onset.” [1]

Fishe and colleagues describe how early diagnosis and treatment helped save the life of a 15-year-old African-American girl with Lyme carditis. [2] The patient was hospitalized after a 3-day history of intermittent retrosternal and epigastric pain. After treatment was initiated, she developed a heart block. Tests for Lyme disease were positive and she was diagnosed with Lyme disease-associated myocarditis.

The adolescent was empirically started on doxycycline and was concurrently treated with milrinone infusion for afterload reduction and intravenous furosemide for pulmonary edema. Her EKG changed to first-degree heart block by day 2 and resolved completely on hospital day 3.

She recovered and was discharged home on hospital day 7 on oral furosemide, enalapril, and doxycycline, according to Fishe and colleagues.

However, another adolescent was not so fortunate. He died suddenly from undiagnosed Lyme carditis, following complaints of flu-like symptoms. The case is discussed in another All Things Lyme blog, Relying on a Negative Lyme Disease Test Can Prove Deadly.

“In patients with Lyme disease who complain of cardiopulmonary symptoms, clinicians should have a low threshold for obtaining an EKG to evaluate for Lyme carditis,” Fishe points out. Furthermore, clinicians should take note that in “children and adolescents, respiratory and gastrointestinal complaints, with or without chest pain, are the most frequent presenting symptoms.”

References:

  1. Muehlenbachs A, Bollweg BC, Schulz TJ et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol, (2016).
  2. Fishe JN, Marchese RF, Callahan JM. Lyme Myocarditis Presenting as Chest Pain in an Adolescent Girl. Pediatr Emerg Care, (2016).

Novel Therapy Destroys Lyme in Lab

https://projectlyme.org/novel-therapy-destroys-lyme-in-lab/

Novel Therapy Destroys Lyme In Lab

Research Identifies New Investigational Therapy Regimen Capable of Irreversibly Damaging Lyme Bacteria in Laboratory Tests

Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases. This project was partially funded by Project Lyme, in partnership with the Bay Area Lyme Foundation. Learn more about our funded research here.

http://

Dr. Neil Spector Research Project

Nov. 1, 2023

PORTOLA VALLEY, Calif. November 1, 2023 – Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the development of a potential new drug, HS-291, that targets and destroys Borrelia burgdorferi, the bacterium that causes Lyme disease. Published in the peer-reviewed journal Cell Chemical Biology, this laboratory study represents a novel paradigm shift for anti-microbial treatment research as it is the first to target and inhibit Borrelia burgdorferi HtpG (high-temperature protein G), a specific type of enzyme within the bacteria that causes Lyme disease— a condition affecting nearly 500,000 new patients annually. The research was conducted at Duke University School of Medicine, with collaboration from the University of North Carolina, Tulane University, and Stanford University, and HS-291 is currently in preclinical stage testing at UC Davis.

“As Lyme disease is currently treated with broad-spectrum antibiotics and there are no targeted treatments, we are particularly excited about this discovery, and hopeful that our novel Lyme disease therapeutic HS-291 will specifically destroy the Lyme bacterium without off-target effects or antibiotic resistance,” said Timothy Haystead, PhD, professor of Pharmacology and Cancer Biology, Duke University School of Medicine, Bay Area Lyme Foundation grantee, and co-lead author. “This research has been an incredible opportunity to leverage knowledge from oncology to Lyme disease to design an investigational therapeutic that could one day benefit hundreds of thousands of patients with Lyme.”

This discovery has implications beyond Lyme disease as it demonstrates that using the drug HS-291 to deliver cellular toxins to HtpG, a type of non-essential enzyme that assists the folding or unfolding of large and complex proteins, greatly expands what can be considered druggable within any pathogen and opens a whole new area of infectious disease research.

When activated, HS-291, an inhibitor of HtpG tethered to the photoactive cellular toxin verteporfin, causes discrete protein modifications, which wreaks havoc on the Lyme disease bacterium’s DNA. This impacts multiple processes including nucleoid collapse and cell wall disruptions. A single dose of HS-291, when activated by light, irreversibly damages Borrelia proteins in close proximity of Bb HtpG in vitro.

“Antibiotics used to treat Lyme disease do not always work for all patients, which causes many to suffer for years with extreme symptoms including neurocognitive issues, disabling fatigue and sleep disruption,” said Linda Giampa, executive director of the Bay Area Lyme Foundation. “Bay Area Lyme concentrates on funding innovative research, including projects where knowledge can be deployed from other areas of medicine. We hope that this discovery will inspire others to join us in investing in impactful, translational research to bring relief to patients.”

This research was made possible by a 2020 Bay Area Lyme Foundation grant of more than $2 million to Duke University School of Medicine in honor of Neil Spector, MD, a renowned oncologist who passed away from complications of Lyme disease that had been misdiagnosed for years. He encouraged scientists to take cancer staging techniques and immunotherapy learnings from oncology and apply them to Lyme research. Dr. Spector was the Sandra Coates associate professor in the Duke University Department of Medicine and also served on Bay Area Lyme Foundation’s Scientific Advisory Board.

Haystead and Spector joined forces as Spector sought to leverage his knowledge of oncology to help better understand Lyme disease, and Haystead’s research is focused on the use of chemical biology approaches to define novel drug targets focused on the treatment of hypertension, obesity, cancer, inflammatory and infectious disease.

Bay Area Lyme Foundation also funded University of North Carolina collaborator, Matt Redinbo, PhD’s research on HS-291; his lab’s crystallography work was instrumental in the discovery process.

Bay Area Lyme Foundation’s research grant program was made possible by the support from the Fairbairn Family, the Younger Family Fund, and Project Lyme.

For more:

Not Good: Medscape – New Federal Oversight of Lab Developed Tests

The following information about “FDA approved” tests is a perfect example of corrupt government agencies doing what they do best: monopolize and control disease for their own purposes – usually financial.

They have restricted doctor and patient choice, care, and access in a number of ways, but one way they cling to like a survivor on a raft is testing. Lyme testing has been fraudulent from the get-go and their suppression of other tests is something that should be made into a movie.  In so many ways the CDC and FDA are maniacal evil twins – both doing all within their power to monopolize medicine.

Dr. Sin Hang Lee has sued the CDC for suppressing direct detection tests for Lyme disease, and promoting their own newly patented, unproven metabolomics technology for diagnosis of LD. Current and former CDC representatives receive royalties as a result of working on the approval and promotion/CDC endorsement of a Lyme disease serology test.

Lee has been fighting back with equal tenacity and performed independent research on faulty COVID testing which showed COVID cases will be overstated by a factor of 72%!

Instead of fixing the obvious errors (no positive control sample, no data on false positives, faulty cycle thresholds, and refusal to publish Ct values due to it being “proprietary”,) HHS, FDA, and CDC opted for arbitrary and perpetual diagnosis of COVID.

It’s important the CDC and FDA control testing because then they can completely steer the narrative about any disease – even if the numbers are all based on faulty testing.  They’ve been doing this in Lymeland for over 40 years by

“setting arbitrary level of antibodies to diagnose a disease that has not been amenable to Koch’s postulates seems open to question.  By the same token, ignoring antibody results unless they meet arbitrary levels seems suspect.  The vast majority of patients in this series showed some WB antibody exposure, but many did not meet the arbitrary limits set….in our present state of knowledge, the diagnosis of chronic Lyme disease is a clinical one.  Many of the patients in this series have suffered serious ‘hurts’ when they have been told that they could not have LD because their WB did not meet arbitrary limits.”  ~ Dr. Burton Waisbren  IDSA founder who disagreed with his colleagues.  RIP

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf/  Video within link (Approx. 10 Min)

Medscape: New Federal Oversight of Lab Developed Tests

Carl Tuttle

Hudson, NH, United States

NOV 1, 2023 — 

Please see the following inquiry sent to Dr. Paul Auwaerter regarding his commentary (verbal diarrhea) published on Medscape.  He has yet to respond to my serious question. Why not email Dr. Auwaerter and demand a response?

Auwaerter’s image was found on his Hopkins profile page:
https://www.hopkinsmedicine.org/profiles/details/paul-auwaerter

———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “pauwaert@jhmi.edu” <pauwaert@jhmi.edu>, “pgauwaerter@gmail.com” <pgauwaerter@gmail.com>
Cc: “aaguilar@webmd.net” <aaguilar@webmd.net>, “DFlapan@Medscape.net” <DFlapan@Medscape.net>, “lkane@medscape.net” <lkane@medscape.net>, “gamiller@medscape.net” <gamiller@medscape.net>, “dolmos@webmd.net” <dolmos@webmd.net>, “sarah.wright@webmd.net” <sarah.wright@webmd.net>, “editor2@webmd.net” <editor2@webmd.net>
Date: 10/25/2023 9:51 AM EDT
Subject: Medscape: New Federal Oversight of Lab Developed
Tests

Medscape COMMENTARY
 
New Federal Oversight of Lab Developed Tests
https://www.medscape.com/viewarticle/997365

Paul G. Auwaerter, MD

Excerpt:

“I often see patients who are concerned they might have Lyme disease, or they’ve been told by other physicians that they have a tickborne or multiple infections. I’ve had patients who claim to have five or six infections: Lyme disease, Babesia, Bartonella, Mycoplasma, or Epstein-Barr virus. They bring LDT results from outside laboratories, which often have a proviso that these tests are only for research or educational purposes. Yet, they purport finding analytes (antibodies or proteins) that suggest the patient has an active infection. These patients may have been treated but are not improving, so they are referred to me.”

Oct 25, 2023

The IDSA Foundation
1300 Wilson Boulevard Suite 300
Arlington, VA 22209
Attn:  Paul Auwaerter, vice chair of the IDSA Foundation

Dear Dr. Auwaerter,

As a member of New Hampshire Governor Chris Sununu’s 2020-2021 commission to study diagnostic testing for Lyme disease, I read your commentary with great interest. After a full year of deliberation, study results concluded that the FDA approved two-tier serologic immunoassay for Lyme was not reliable in all stages of disease. (No better than a coin toss)

COMMISSION TO STUDY TESTING FOR LYME AND OTHER TICK-BORNE DISEASES
https://www.gencourt.state.nh.us/statstudcomm/committees/default.aspx?id=1515

“A commission to study the role of clinical diagnosis and the limitations of serological diagnostic tests in determining the presence or absence of Lyme and other tick-borne diseases”
 
With that conclusion, serology cannot be used to determine who has or does not have Lyme disease.

“FDA approval” (Federal Oversight) has failed miserably in this example.

The CDC has warned the medical community that “surveillance case definitions” (which include the IgM and IgG Western blot serologic bands) are not to be used for making a clinical diagnosis:

From the CDC website:

Lyme Disease (Borrelia burgdorferi)
2022 Case Definition
https://ndc.services.cdc.gov/case-definitions/lyme-disease-2022/

NOTE: A surveillance case definition is a set of uniform criteria used to define a disease for public health surveillance. Surveillance case definitions enable public health officials to classify and count cases consistently across reporting jurisdictions. Surveillance case definitions are not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.
________________________

Recent announcements:

1. “Standard” Lyme testing once again proves fatal
https://www.lymedisease.org/lyme-testing-proves-fatal/

“Lyme disease helped kill our son. A better test might have saved him.”

2. Sensitivity of Two-Tiered Lyme Disease Serology in Children with an Erythema Migrans Lesion 
https://doi.org/10.1093/jpids/piad073

Abstract

In our prospective cohort of 192 children with a physician-diagnosed erythema migrans (EM) lesion, two-tier Lyme disease serology had higher sensitivity in children with multiple EM lesions (76.8% multiple lesions vs. 38.1% single EM; difference 38.7%, 95% CI 24.8 to 50.4%). The diagnosis of cutaneous Lyme disease should be based on careful physical examination rather than laboratory testing.

3. Jury awards $6.5M to Maine family for wrongful death, negligent misdiagnosis
https://fox23maine.com/news/local/jury-awards-65m-to-maine-family-for-wrongful-death-negligent-misdiagnosis-mercy-hospital-dr-john-henson-peter-smith-lyme-disease-lyme-carditis-physicians

Court records show Dr. Henson diagnosed smith with a skin disorder and a virus, writing “no sign of Lyme Disease.” Smith died of Lyme carditis.

(I understand that serology was NEGATIVE in this case)

Question:

Dr. Auwaerter…  I would like to call attention to the following 2009 tick study conducted here in New Hampshire:

Correlation between Tick Density and Pathogen Endemicity, New Hampshire
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671416/

The study found deer ticks were carrying multiple pathogens (co-infections) that could be transmitted in a single bite.

What FDA approved Tick-Borne Disease Panel are you recommending so as not to miss any of these infections?

A response to this inquiry is requested
Carl Tuttle
Hudson, NH

Cc: MEDSCAPE EDITORIAL STAFF

Additional reference:

“Seronegativity in Lyme borreliosis and Other Spirochetal Infections” 16 September 2003
https://www.dropbox.com/s/3d6m45jzlhhwalu/Seronegativity.pdf?dl=0

“If false results are to be feared, it is the false negative result which holds the greatest peril for the patient.”

Spike Protein in Heart Cells Within 48 Hours of Injection

https://www.theepochtimes.com/health/mrna-covid-vaccines-form-spike-protein-in-heart-cells-but-cause-different-anomalies-research-article

mRNA COVID Vaccines Form Spike Protein in Heart Cells, but Cause Different Anomalies: Research Article

New research observing rat and human heart cells shows that within 48 hours of vaccination, the COVID-19 mRNA vaccines form spike proteins.
10/22/2023

New research out of Germany observing rat and human heart cells shows that within 48 hours of vaccination, the COVID-19 mRNA vaccines form spike proteins.

Spike proteins, made from the mRNA instructions inside the vaccines, were detected in the heart cells. While both Pfizer and Moderna vaccines caused cell abnormalities, the two induced different anomalies.

The different responses the cells had to the two mRNA vaccines suggest an mRNA toxicity reaction in these cells, according to Dr. Peter McCullough, a leading internist, cardiologist, and epidemiologist who has published over 1,000 research reports and is the lead author of one of the first widely utilized treatment regimens for SARS-CoV-2 patients. He added that 48 hours was a short amount of time to observe this.

The findings support both the diagnosis and treatment of cardiac events following mRNA-based COVID vaccination,” the authors wrote, adding that the findings may explain persistent cardiac symptoms among long-COVID patients.(See link for article)

_____________

**Comment**

The article has now been updated and includes a video comparing unvaxxed rat heart cells vs vaxxed.  They found:

  • Pfizer-“vaxxed” cells displayed stronger, sustained contractions (1B) due to increased protein kinase A (PKA) activity. PKA levels are linked to heart performance; the higher the PKA level, the stronger the heart contractions.
  • Moderna-“vaxxed” cells developed irregular heart contractions and disrupted calcium regulation. The authors attributed the change in cell activity to disturbances in RyR2 receptors. These receptors play a key role in coordinating heart contractions using calcium. Some of the heart muscles administered Moderna vaccines developed irregular and peristaltic contractions (1C and 1D), whereas others had irregular and arrhythmic contractions (1E and 1F).

The authors also found damage is closer to cardiomyopathy by toxic stress (heart muscles are structurally and functionally abnormal in the absence of other heart diseases) than myocarditis & pericarditis (heart muscles are inflamed and damaged.)

Also, the varying responses indicate the cardiac abnormalities may suggest toxicity in the mRNA itself rather than the spike protein which both injections have.

For more:

How ‘the powers that be’ are covering up the injection damage:

How the injections are causing heart damage:

The Link Between Nightshades, Chronic Pain and Inflammation

https://greenmedinfo.com/blog/link-between-nightshades-chronic-pain-and-inflammation

The Link Between Nightshades, Chronic Pain and Inflammation

“© [Article Date] GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here //www.greenmedinfo.com/greenmed/newsletter.”

Few people are familiar with the term nightshades, and many will be surprised to learn that consuming foods from this plant group may be contributing to their pain and inflammation

Nightshades belong to the Solanaceae family which includes over 2,000 species. They also include some of the most popular foods consumed today; such as tomatoes, potatoes, all types of peppers, and eggplant. Although not truly nightshades, blueberries, huckleberries, goji berries and ashwaganda all share the same alkaloids which may have inflammation-inducing properties.

The Solanaceae family contains cholinesterase inhibiting glycoalkaloids and steroid alkaloids including, among others, solanine in potato and eggplant, tomatine in tomato, nicotine in tobacco, and capsaicin in garden peppers. The glycoalkaloids in potatoes are known to contribute to Irritable Bowel Syndrome (IBS) and negatively affect intestinal permeability. (1,2) According to Dr. Marvin Childers, When these inhibitors accumulate in the body, alone or with other cholinesterase inhibitors such as caffeine or food impurities containing systemic cholinesterase inhibiting pesticides, the result may be a paralytic-like muscle spasm, aches, pains, tenderness, inflammation, and stiff body movements.” (3) These symptoms may dissipate in a few hours or days if ingestion is stopped, based on the sensitivity of the individual, the amount of nightshades consumed on a regular basis and their level of inflammation. However for some heavy consumers of nightshades the process of inflammation and pain reduction can take up to 3 months.

After reading the symptoms associated with nightshade consumption, it is easy to understand why one of the major problems attributed to nightshade is arthritis. Arthritis is also the most common disability in the U.S. (4,5) Statistics from a 2007-2009 study show that doctor diagnosed arthritis affects 49.9 million people in the United States alone (6). Osteoarthritis is the most common form of arthritis affecting more than 20 million people. More than 2 million people are affected by rheumatoid arthritis, the most disabling and painful form of arthritis. Arthritis has no boundaries to gender, race or age, it affects young and old alike. (5, 7) In fact it may be surprising to some that an estimated 294,000 children (age 18 and under), have some form of arthritis. (7) In 2003 the medical cost of arthritis alone was approximately 128 billion annually. (4) Since 1994, disability-related costs for medical care and lost productivity have exceeded an estimated $300 billion annually in the United Statesthis includes arthritis and other rheumatoid related illness (8) Add to these numbers the report released in 2011 by the Institute of Medicine of the National Academies, where an estimated 116 million adults live with chronic pain, which costs the United States $635 billion annually in health care and lost productivity. (9) So the question is how much of these problems are nightshade related? That is the question some researchers are asking, as they believe that arthritis is often misdiagnosed in people who may in fact be experiencing severe side effects of nightshade consumption.

Many who suffer with arthritis or an arthritis related disease such as lupus, rheumatism, and other musculoskeletal pain disorders, have found that consuming foods from the nightshade family is in fact adversely affecting their health. Norman F. Childers, PhD, founder of the Arthritis Nightshades Research Foundation stated: “Diet appears to be a factor in the etiology of arthritis based on surveys of over 1400 volunteers during a 20-year period. Plants in the drug family, Solanaceae (nightshades) are an important causative factor in arthritis in sensitive people.” (3)

Three month challenge

If you want to know if nightshades negatively affect you, take the three month challenge. Avoid all nightshades for three months. (It’s called a challenge for a reason).Be careful to note the nightshade list, and become a label reader as some homeopathics, prescriptions, over the counter medications as well as numerous processed foods contain nightshades. Prescriptions and over the counter medicines may require a discussion with your pharmacist or a phone call to the manufacturer of your over the counter medicines to determine ingredients.

After three months, begin to reintroduce one nightshade at a time. Take note of any aches, pains, stiffness, and loss of energy, headaches, respiratory problems or any other symptoms. You may find as many others have, that the quality of your daily health will dramatically improve after eliminating nightshades from your diet.

The nightshade list

  • ­ tomatoes (all varieties, including tomatillos)
  • ­ potatoes (all varieties, NOT sweet potatoes or yams)
  • ­ eggplant (aubergine)
  • ­ okra
  • ­ peppers (all varieties such as bell pepper, wax pepper, green & red peppers, chili peppers, cayenne, paprika, etc.)
  • ­ goji berries
  • ­ tomarillos (a plum-like fruit from Peru)
  • ­ sorrel
  • ­ garden huckleberry & blueberries (contain the alkaloids that induce inflammation)
  • ­ gooseberries
  • ­ ground cherries
  • ­ pepino Melon
  • ­ the homeopathic “Belladonna” [note: this is highly precautionary as homeopathics contain virtually no measurable “active” chemical]
  • ­ tobacco
  • ­ paprika
  • ­ cayenne pepper

Soy sauce made in the U.S. is generally made with genetically modified (GMO) soy beans, which are cut with the nightshade plant Petunia.

The condiments black/white pepper and pepper corns are not nightshades

Other ingredients and products to avoid

  • ­Homeopathic remedies containing Belladonna [note: this is highly precautionary as homeopathics contain virtually no measurable “active” chemical]
  • ­Prescription and over-the-counter medications containing potato starch as a filler (especially prevalent in sleeping and muscle relaxing medications)
  • ­Edible flowers: petunia, chalice vine, day jasmine, angel and devil’s trumpets
  • ­Atropine and Scopolamine, used in sleeping pills
  • ­Topical medications for pain and inflammation containing capsicum (in cayenne pepper).
  • ­Many baking powders contain potato starch
  • ­Don’t lick envelopes, many adhesives contain potato starch
  • ­Vodka (potatoes used in production)

Read labels carefully because you could be doing everything else right, and still be sabotaged by one small amount of an ingredient.

Never buy a food has that uses the generic term of seasoning or spices…. nightshades may be included in the ingredients.

Learn more about the similarity of tomato lectin with wheat germ lectin (WGA), as well as lectins found in rice and barley:

Rice, Potato, and Tomato May Be As Inflammatory As Wheat


References

1. Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. www.greenmedinfo.com/article/potato-glycoalkaloids-adversely-affect-intestinal-permeability-and-aggravate

2. Naturally occurring glycoalkaloids in potatoes aggravate intestinal inflammation in two mouse models of inflammatory bowel disease. www.greenmedinfo.com/article/naturally-occurring-glycoalkaloids-potatoes-aggravate-intestinal-inflammation-two-mouse

3. Journal of Neurological and Orthopedic Medical Surgery (1993) 12:227-231.An Apparent Relation of Nightshades (Solanaceae) to Arthritis https://www.noarthritis.com/research.htm

4. National and State Medical Expenditures and Lost Earnings Attributable to Arthritis and Other Rheumatic Conditions — United States, 2003 https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5601a2.htm?s_cid=mm5601a2_e

5. Differences in the Prevalence and Impact of Arthritis Among Racial/Ethnic Groups in the United States, National Health Interview Survey, 2002, 2003, and 2006 https://www.cdc.gov/pcd/issues/2010/may/10_0035.htm

6. Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation – United States, 2007-2009 https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5939a1.htm?s_cid=mm5939a1_w

7. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001-2004. Sacks JJ, Helmick CG, Luo YH, Ilowite NT, Bowyer S. https://www.ncbi.nlm.nih.gov/pubmed?Db=pubmed&Cmd=ShowDetailView&TermToSearch=18050185&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

8. Prevalence and Most Common Causes of Disability Among Adults — United States, 2005 https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5816a2.htm

9. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research https://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research.aspx

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.